Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of inhaled fluticasone furoate on short-term growth in paediatric asthma
2015-000841-22Phase 3Completed
- Sponsor
- GSK
- Start
- May 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone in asthma (2 arms), sponsored by GSK. Primary endpoint: Mean lower-leg growth rate. Started May 2015; status: completed.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-000841-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000841-22.